PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent Pericarditis PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™

Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index